​

Funding Round

Series B - Be Biopharma

Series B - Be Biopharma

Investment Firm

Overview

Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.

Announced Date

Apr 14, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorLongwood Fund
Participant InvestorAlta Partners
Participant InvestorBristol-Myers Squibb
Participant InvestorAtlas Venture
Participant InvestorARCH Venture Partners

Round Details and Background

Be Biopharma raised $130000000 on 2022-04-14 in Series B

Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 22, 2020
Series A - Be Biopharma
5-52.0M
Apr 14, 2022
Series B - Be Biopharma
7-130.0M

Recent Activity

There is no recent news or activity for this profile.